GlassScriptPhysician profile
Jason Ramsey
NPI 1447479787
$12,813.13
in general payments reported to CMS, 2019-2025
24 companies · $2,561 in 2025
The $2,561 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,668 · 2020: $69.60 · 2021: $2,129 · 2022: $1,064 · 2023: $1,615 · 2024: $1,708 · 2025: $2,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,244 · Food and Beverage: $2,242 · Consulting Fee: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,243.74 |
| Food and Beverage | $2,242.35 |
| Consulting Fee | $397.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $7,867.94 | 2019-2025 | Djo Surgical |
| Rattan and Associates | $2,007.90 | 2019-2025 | |
| Vericel Corporation | $1,470.23 | 2023-2025 | Maci |
| Arthrex, INC. | $252.28 | 2024 | |
| Linvatec Corporation | $200.42 | 2024 | Biobrace 23mm |
| Globus Medical, INC. | $168.10 | 2024 | Harvest |
| Pacira Therapeutics, INC. | $150.00 | 2019-2020 | |
| Dynasplint Systems INC. | $139.86 | 2021 | |
| Stryker Corporation | $83.54 | 2023-2024 | Microfx Ocd, Iconix |
| Bioventus LLC | $65.19 | 2020-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $63.25 | 2025 | |
| Orthofix Medical, INC. | $60.17 | 2024-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $55.71 | 2022-2023 | Monovisc |
| Kowa Pharmaceuticals America, INC. | $46.45 | 2022-2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $28.99 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $19.83 | 2023 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $19.82 | 2024 | Exparel, Zilretta, Iovera |
| Abbott Laboratories | $19.50 | 2024 | Proclaim |
| Abbvie INC. | $17.65 | 2024 | |
| Anika Therapeutics, INC. | $17.48 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.66 | 2019 | |
| Axogen | $15.15 | 2019 | |
| Baudax Bio INC. | $13.51 | 2020 | |
| Merck Sharp & Dohme LLC | $13.50 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Ramsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.